Healthed AustraliaHealthed Australia

Lagevrio questions, mRNA jab misunderstandings and nasal vaccines coming

View descriptionShare

Episode 207

  • Despite a panoramic study suggesting a lower effect, Lagevrio has a useful impact on hospitalisations, deaths and shorter recovery time

  • COVID trials becoming more difficult to run because so many people have either been vaccinated and / or exposed

  • How the Pfizer vaccination’s lack of impact on transmission is not a cause for concern and was clearly communicated since its release. The main impact is the reduction of severity, hospitalisations and death, and the data for this hasn’t changed

  • How a nasal vaccination might be coming

Host: David Lim | Total Time: 21 mins

Guest: A/Prof Paul Griffin, Infectious Diseases Physician and Clinical Microbiologist

Register for our fortnightly FREE WEBCASTS
Every second Tuesday | 7:00pm-9:00pm AEDT

Click here to register for the next one

In 1 playlist(s)

  1. Going Viral Podcast

    230 clip(s)

Healthed Australia

Healthed's medical education channel features the latest high quality clinical interviews and lectur 
Social links
Recent clips
Browse 189 clip(s)